Moderna's chief legal officer Shannon Klinger to retire under agreement filed November 13Nov 13PeopleModerna, Inc.
Evaxion presents new EVX-01 immune data at SITC, showing ex vivo T-cell detectionNov 6Clinical readoutBioNTech SEEvaxion Biotech A/SUpdated
Moderna posts Phase 2 mRNA-1083 results; VX-522 completes; new Phase 3b/4 study registersOct 9Weekly roundup, 3 itemsModerna, Inc.Vertex Pharmaceuticals Inc / Ma
Moderna completes $3 billion convertible notes offering, upsized from original planSep 1FinancingModerna, Inc.
Moderna's norovirus vaccine misses early efficacy bar; flu shot nears FDA decisionJul 31Quarterly updateModerna, Inc.